Journal Article
. 2012 Mar; 19(5):336-44.
doi: 10.1038/cgt.2012.6.

Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression

J Melo-Cardenas 1 M Urquiza  T J Kipps  J E Castro  
Affiliations
  • PMID: 22402624
  •     46 References
  •     5 citations

Abstract

Ad-ISF35 is an adenovirus (Ad) vector that encodes a mouse-human chimeric CD154. Ad-ISF35 induces activation of chronic lymphocytic leukemia (CLL) cells converting them into CLL cells capable of promoting immune recognition and anti-leukemia T-cell activation. Clinical trials in humans treated with Ad-ISF35-transduced leukemia cells or intranodal injection of Ad-ISF35 have shown objective clinical responses. To better understand the biology of Ad-ISF35 and to contribute to its clinical development, we preformed studies to evaluate biodistribution, persistence and toxicity of repeat dose intratumoral administration of Ad-ISF35 in a mouse model. Ad-ISF35 intratumoral administration induced tumor regression in more than 80% of mice bearing A20 tumors. There were no abnormalities in the serum chemistry. Mice receiving Ad-ISF35 presented severe extramedullary hematopoiesis and follicular hyperplasia in the spleen and extramedullary hematopoiesis with lymphoid hyperplasia in lymph nodes. After Ad-ISF35 injection, the vector was found primarily in the injected tumors with a biodistribution pattern that showed a rapid clearance with no evidence of Ad-ISF35 accumulation or persistence in the injected tumor or peripheral organs. Furthermore, pre-existing antibodies against Ad-5 did not abrogate Ad-ISF35 anti-tumor activity. In conclusion, intratumoral administration of Ad-ISF35 induced tumor regression in A20 tumor bearing mice without toxicities and with no evidence of vector accumulation or persistence.

Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.
Che-Leung Law, Iqbal S Grewal.
Adv Exp Med Biol, 2009 Sep 18; 647. PMID: 19760064
Review.
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.
David P Inwald, Alison McDowall, +2 authors, Nigel J Klein.
Circ Res, 2003 Apr 05; 92(9). PMID: 12676820
Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
J L Bramson, M Hitt, J Gauldie, F L Graham.
Gene Ther, 1998 Feb 12; 4(10). PMID: 9415313
Factors influencing retention of adenovirus within tumours following direct intratumoural injection.
M Bazan-Peregrino, R C Carlisle, L Purdie, L W Seymour.
Gene Ther, 2008 Feb 22; 15(9). PMID: 18288207
Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma.
S Serba, J Schmidt, +2 authors, A Märten.
Gut, 2007 Aug 07; 57(3). PMID: 17675324
Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis.
T Sparwasser, L Hültner, +3 authors, H Wagner.
J Immunol, 1999 Feb 11; 162(4). PMID: 9973517
The role of CD40 and CD154/CD40L in dendritic cells.
Daphne Y Ma, Edward A Clark.
Semin Immunol, 2009 Jun 16; 21(5). PMID: 19524453    Free PMC article.
Highly Cited. Review.
Prospects for CD40-directed experimental therapy of human cancer.
Alex W Tong, Marvin J Stone.
Cancer Gene Ther, 2002 Dec 19; 10(1). PMID: 12489023
Review.
Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions.
Kalyan Pande, Roanna Ueda, +10 authors, Drake M LaFace.
Mol Ther, 2009 Jan 08; 17(3). PMID: 19127252    Free PMC article.
CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.
W G Wierda, M J Cantwell, +3 authors, T J Kipps.
Blood, 2000 Oct 26; 96(9). PMID: 11049967
Innate control of B cell responses.
Andrea Cerutti, Irene Puga, Montserrat Cols.
Trends Immunol, 2011 Mar 23; 32(5). PMID: 21419699    Free PMC article.
Review.
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.
W G Wierda, J E Castro, +6 authors, T J Kipps.
Leukemia, 2010 Oct 01; 24(11). PMID: 20882050    Free PMC article.
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Yair Herishanu, Patricia Pérez-Galán, +21 authors, Adrian Wiestner.
Blood, 2010 Oct 14; 117(2). PMID: 20940416    Free PMC article.
Highly Cited.
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Gregory L Beatty, Elena G Chiorean, +10 authors, Robert H Vonderheide.
Science, 2011 Mar 26; 331(6024). PMID: 21436454    Free PMC article.
Highly Cited.
Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
B G Harvey, N R Hackett, +5 authors, R G Crystal.
J Virol, 1999 Jul 10; 73(8). PMID: 10400771    Free PMC article.
Friends or foes - bipolar effects of the tumour stroma in cancer.
Margareta M Mueller, Norbert E Fusenig.
Nat Rev Cancer, 2004 Nov 02; 4(11). PMID: 15516957
Highly Cited. Review.
Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance.
N Wolins, J Lozier, +3 authors, J G Vostal.
Br J Haematol, 2003 Nov 25; 123(5). PMID: 14632782
Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy.
Z Hu, A Garen.
Proc Natl Acad Sci U S A, 2000 Aug 02; 97(16). PMID: 10922073    Free PMC article.
Bone marrow microenvironment and tumor progression.
Christophe F Chantrain, Olivier Feron, Etienne Marbaix, Yves A DeClerck.
Cancer Microenviron, 2009 Mar 25; 1(1). PMID: 19308682    Free PMC article.
Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation.
Thomas L Eggerman, Traci Heath Mondoro, Jay N Lozier, Jaroslav G Vostal.
Hum Gene Ther, 2002 Jan 10; 13(1). PMID: 11779416
The role of the CD40 pathway in the pathogenesis and treatment of cancer.
Aristides G Eliopoulos, Lawrence S Young.
Curr Opin Pharmacol, 2004 Jul 15; 4(4). PMID: 15251129
Review.
Toxicity of a first-generation adenoviral vector in rhesus macaques.
Jay N Lozier, Gyorgy Csako, +7 authors, Richard A Morgan.
Hum Gene Ther, 2002 Jan 10; 13(1). PMID: 11779415
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Michael Hallek, Bruce D Cheson, +9 authors, International Workshop on Chronic Lymphocytic Leukemia.
Blood, 2008 Jan 25; 111(12). PMID: 18216293    Free PMC article.
Highly Cited.
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
Joo-Hang Kim, Young-Sook Lee, +3 authors, Chae-Ok Yun.
J Natl Cancer Inst, 2006 Oct 19; 98(20). PMID: 17047197
Effects of rate, volume, and dose of intratumoral infusion on virus dissemination in local gene delivery.
Yong Wang, He Wang, Chuan-Yuan Li, Fan Yuan.
Mol Cancer Ther, 2006 Mar 01; 5(2). PMID: 16505110
Specific antibodies modulate the interactions of adenovirus type 5 with dendritic cells.
S Mercier, H Rouard, M H Delfau-Larue, M Eloit.
Virology, 2004 Apr 28; 322(2). PMID: 15110528
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.
Parameshwar J Mahasreshti, Manjula Kataram, +7 authors, David T Curiel.
Clin Cancer Res, 2003 Jul 12; 9(7). PMID: 12855650
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.
B D Cheson, J M Bennett, +4 authors, K R Rai.
Blood, 1996 Jun 15; 87(12). PMID: 8652811
Highly Cited.
Immune responses to adenovirus and adeno-associated virus in humans.
N Chirmule, K Propert, +3 authors, J Wilson.
Gene Ther, 1999 Sep 22; 6(9). PMID: 10490767
Highly Cited.
CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
P Chu, W G Wierda, T J Kipps.
Blood, 2000 Jun 14; 95(12). PMID: 10845920
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
Dirk Lievens, Wouter J Eijgelaar, +2 authors, Esther Lutgens.
Thromb Haemost, 2009 Aug 05; 102(2). PMID: 19652870
Review.
Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response.
Randall S MacGill, Thomas A Davis, +3 authors, C Richter King.
Clin Exp Metastasis, 2007 Jul 27; 24(7). PMID: 17653822
Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1.
Matthew J Cotter, Anne K Zaiss, Daniel A Muruve.
J Virol, 2005 Nov 12; 79(23). PMID: 16282462    Free PMC article.
Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.
Zhili Xu, Jeffrey S Smith, Jie Tian, Andrew P Byrnes.
Mol Ther, 2009 Dec 03; 18(3). PMID: 19953082    Free PMC article.
Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery.
Y Wang, Z Yang, +4 authors, F Yuan.
Br J Cancer, 2005 Apr 07; 92(8). PMID: 15812558    Free PMC article.
Histopathology of the spleen.
Andrew W Suttie.
Toxicol Pathol, 2006 Oct 28; 34(5). PMID: 17067940
Review.
Therapeutic targeting of the tumor microenvironment.
Johanna A Joyce.
Cancer Cell, 2005 Jun 14; 7(6). PMID: 15950901
Highly Cited.
Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.
K Kato, M J Cantwell, S Sharma, T J Kipps.
J Clin Invest, 1998 Apr 16; 101(5). PMID: 9486984    Free PMC article.
Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response.
J Reay, S-H Kim, +2 authors, P D Robbins.
Cancer Gene Ther, 2009 Apr 25; 16(10). PMID: 19390568    Free PMC article.
Rapid Kupffer cell death after intravenous injection of adenovirus vectors.
Elanchezhiyan Manickan, Jeffrey S Smith, +4 authors, Andrew P Byrnes.
Mol Ther, 2005 Oct 04; 13(1). PMID: 16198149
Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits.
G Cichon, H H Schmidt, +9 authors, M Strauss.
J Gene Med, 2000 Mar 30; 1(5). PMID: 10738553
Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors.
F Lohr, Q Huang, +2 authors, C Y Li.
Clin Cancer Res, 2001 Nov 14; 7(11). PMID: 11705885
Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy.
Y Chen, D C Yu, D Charlton, D R Henderson.
Hum Gene Ther, 2000 Aug 17; 11(11). PMID: 10945769
Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression.
Caroline Oberholzer, Andreas Oberholzer, +5 authors, Lyle L Moldawer.
J Endotoxin Res, 2004 Dec 14; 10(6). PMID: 15588421
Antitumor responses induced by transgenic expression of CD40 ligand.
M E Grossmann, M P Brown, M K Brenner.
Hum Gene Ther, 1998 Feb 07; 8(16). PMID: 9382959
CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
R Buhmann, A Nolte, +2 authors, M Hallek.
Blood, 1999 Mar 09; 93(6). PMID: 10068672
Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.
Januario E Castro, Johanna Melo-Cardenas, +3 authors, Thomas J Kipps.
Cancer Res, 2012 Apr 17; 72(12). PMID: 22505652    Free PMC article.
Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.
Mauricio Urquiza, Johanna Melo-Cardenas, +2 authors, Januario E Castro.
Hum Gene Ther, 2014 Nov 11; 26(1). PMID: 25382101    Free PMC article.
Nanocarrier-based immunotherapy in cancer management and research.
Manu Smriti Singh, Sangeeta Bhaskar.
Immunotargets Ther, 2014 Jan 01; 3. PMID: 27471704    Free PMC article.
Review.
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
Manisha Singh, Christina Vianden, +15 authors, Willem W Overwijk.
Nat Commun, 2017 Nov 14; 8(1). PMID: 29129918    Free PMC article.
Immune-Checkpoint Inhibitors in B-Cell Lymphoma.
Marc Armengol, Juliana Carvalho Santos, +3 authors, Gaël Roué.
Cancers (Basel), 2021 Jan 13; 13(2). PMID: 33430146    Free PMC article.
Review.